NWMG
CATX icon

Nicholson Wealth Management Group’s Perspective Therapeutics CATX Stock Holding History

Nicholson Wealth Management Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.52M Buy
1,619,993
+1,000
+0.1% +$3.78K 3.25% 1
2026
Q1 		$6.75M Buy
1,618,993
+1,000
+0.1% +$4.22K 3.93% 1
2025
Q4 		$4.45M Sell
1,617,993
-300
-0% -$856 2.61% 2
2025
Q3 		$5.55M Buy
1,618,293
+4,010
+0.2% +$14.6K 3.25% 2
2025
Q2 		$5.55M Buy
1,614,283
+5,000
+0.3% +$13.2K 3.42% 2
2025
Q1 		$3.43M Hold
1,609,283
– – 2.25% 2
2024
Q4 		$5.13M Buy
1,609,283
+7,000
+0.4% +$57.2K 3.43% 2
2024
Q3 		$21.4M Buy
+1,602,283
New +$21.3M 17.57% 1

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Nicholson Wealth Management Group's CATX Position: Q2 2026 in Review

Nicholson Wealth Management Group increased its Perspective Therapeutics (CATX) stake by 0.06% in Q2 2026, buying an estimated $3.78K and bringing the position to 1,619,993 shares worth $5.52M. The position accounts for 3.25% of the portfolio, ranked #1.

Nicholson Wealth Management Group first reported a position in CATX in Q3 2024 and has held it in 8 quarters since. The position peaked at $21.4M in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Nicholson Wealth Management Group held 1,619,993 shares of Perspective Therapeutics worth $5.52M as of Q2 2026.
  • Nicholson Wealth Management Group bought 1,000 Perspective Therapeutics shares in Q2 2026, an estimated $3.78K.
  • Perspective Therapeutics made up 3.25% of Nicholson Wealth Management Group's portfolio in Q2 2026, its #1 holding.
  • Nicholson Wealth Management Group first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Nicholson Wealth Management Group's Perspective Therapeutics position peaked at $21.4M in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Nicholson Wealth Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.